Kelly S. Ramsey, MD, MPH, MA, FACP
Education Committee Chairperson
Regional Director to ASAM
Chief of Medical Services, NYS OASAS
Dr. Kelly S. Ramsey is an internal medicine physician who has treated substance use disorder since 2004. She is board certified in internal medicine and addiction medicine. Dr. Ramsey currently works as the Chief of Medical Services at NYS OASAS. Dr. Ramsey was the recipient of the NYS DOH Commissioner’s Special Recognition Award for contributions to drug user health in NYS in December 2018. Some of Dr. Ramsey’s clinical interests in addiction include: opioid use disorder, harm reduction, overdose prevention, the impact of language and stigma on healthcare engagement for people who use drugs (PWUD), substance use disorder in pregnant and parenting persons, and HIV and HCV diagnosis, engagement in care, and treatment for PWUD.
Timothy Wiegand, MD
Nomination Committee Chair
Director of Medical Toxicology and Toxicology Consult Service,
Associate Clinical Professor of Emergency Medicine
URMC and Strong Memorial Hospital
Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM is Program Director for the URMC Addiction Medicine Fellowship Program, and the Medical Director for Huther Doyle, an addiction services provider in Rochester, New York, where he works in a collaborative model providing a variety of services for patients with substance use disorders, and serves as facilitator for their Project ECHO program on Pain, Opioid Prescribing and Addiction. In addition to ED, hospital and clinic work treating drug exposures, intoxication, withdrawal and assisting with pain management for patients maintained on medications for opioid use disorder (MOUD) in the ED, hospital and perioperative setting, Dr. Wiegand is involved with medical education and research in toxicology and addiction.
Aaron D. Fox, MD
Public Policy Chair
Associate Professor of Medicine
Albert Einstein College of Medicine/Montefiore Medical Center
Dr. Aaron Fox is board certified in internal medicine and addiction medicine. His clinical care and research involves opioid use disorder treatment in primary care, syringe services programs, and criminal justice settings. Dr. Fox is the Director of the Bronx Transitions Clinic, which provides a medical home to people who were recently released from jail or prison, and he maintains an NIH-funded program of clinical research focused on buprenorphine treatment interventions.
Ross Sullivan, MD
Director-Medical Toxicology Consultation Service
Upstate Medical University Hospital-Syracuse
Kristine Torres-Lockhart, MD
Assistant Professor of Medicine and Psychiatry and Behavioral Sciences at Montefiore Medical Center and Albert Einstein College of Medicine
Dr. Torres-Lockhart is board certified in addiction medicine and internal medicine and credentialed as an HIV specialist by the AAHIVM. She is founding director of the Addiction Consult Service at Montefiore’s Weiler Hospital and co-director of the Addiction Medicine rotation for medical trainees. She is focused on integrating addiction medicine into medical education and leads the development and implementation of health system interventions to improve substance use disorder (SUD) care in acute care settings and transitions of care to post-acute and ambulatory care settings.
Merrill Herman, MD
Membership Committee Chair
Associate Professor of Clinical Psychiatry at Montefiore/Einstein
917-564-8771 or 718-920-6770
Dr. Herman has a long-standing interest in the treatment of Co-occurring Psychiatric Disorders and Substance Use Disorders (Dual Diagnosis) including both psychotherapeutic and pharmacologic management. In addition, I have a long-standing interest in the treatment of OUD, especially working with methadone patients. In addition, oversees the Addiction Psychiatry Fellowship at Montefiore/Einstein and is passionate about education in the field. Additionally he is the former Founding President of NYSAM, current member of the Nominating Committee and member of the ASAM National Membership Council.
Linda Wang, MD
Education and Program Committee Chair
Assistant Professor in the Division of General Internal Medicine at the Icahn School of Medicine at Mount Sinai
Dr. Linda Wang is a general internist and addiction medicine specialist who cares for people who use drugs at the REACH Program at Mount Sinai, where she also directs the buprenorphine treatment program. She is the Medical Director for the Hepatitis C and Drug User Health Center of Excellence at the Institute for Advanced Medicine at Mount Sinai, part of the New York State Clinical Education Initiative. She is an active clinician educator who is interested in expanding access to substance use disorder treatment, stigma-free care for people who use drugs, and training current and future clinicians in drug user health.
Neha Pawar, MD
Early Career Member
Senior Instruction, Department of Anesthesiology and Perioperative Medicine and Addiction Medicine/Psychiatry
Dr. Neha Pawar has specialized in the treatment of Addiction and Pain Medicine. She completed her residency in psychiatry and fellowships in Pain Medicine, Department of Anesthesiology and Addiction Medicine /Psychiatry, and Department of Psychiatry at the University of Rochester Medical Center. She joined as a senior instructor at Strong memorial hospital in Oct 2021 and works at Cancer Pain Center at Wilmot Cancer Center and Chemical dependency outpatient clinic, Strong Recovery.
Madeleine Walsh, RN, BSN
Medical Student/Resident/Fellow BOD Member
NYU School of Medicine Medical Student
Madeleine Walsh is a medical student at NYU School of Medicine who is interested in working with pregnant and peripartum individuals with substance use disorder. Her research thus far has focused on homelessness during pregnancy and sexual and gender-based violence. She plans on completing an Ob/Gyn residency and an addiction medicine fellowship. Madeleine received her RN and BSN from University of Michigan and worked as a labor and delivery nurse prior to starting medical school.
Dorothy Lennon, MD, DFASAM
At Large Member
Syracuse Recovery Services
Dr. Dorothy Lennon’s clinical interests include: physician health, stigma reduction, MOUD and 12-step recovery.
Tiffany Lu, MD, MS, FASAM
At Large Member
Assistant Professor of Medicine, Montefiore Medical Center and Albert Einstein College of Medicine
Dr. Tiffany Lu is an internal medicine physician and addiction medicine specialist at Montefiore Medical Center and Albert Einstein College of Medicine. She is the Medical Director of the Montefiore Buprenorphine Treatment Network, which provides opioid use disorder treatment and overdose prevention at 6 community health centers across Bronx, NY. She also leads addiction medicine education for medical students and internal medicine residents at Montefiore-Einstein. Dr Lu’s research focus is on buprenorphine treatment delivery and outcomes in low-income and racial minority communities disproportionally affected by the overdose crisis.